Chare M J, Baum M
Dev Biol Stand. 1977;38:195-200.
The anti-tumour activity of C. parvum is thought to be mediated via the monocyte/macrophage system (Scott, 1974). These cells originate from rapidly dividing precursors in the bone marrow and it might be at this level that C. parvum exerts its action. To test this hypothesis bone marrow T0 Swiss mice has been cultured according to the method of Bradley and Metcalf (1966), which gives an index of the number of proliferating macrophage precursor cells at the time of sacrifice. Experiments were set up at various times following a single i.p. injection of 700 microgram of an anti-tumour strain of C. parvum (CN 6134-Wellcome Research Laboratories). Controls received 700 microgram of either C. diphtheriae CN 2000 or C. parvum CN 5888, a strain with no anti-tumour activity. Macrophage colony counts in those mice receiving "active" C. parvum were significantly higher than those in controls at intervals from 2 h to 3 weeks post-treatment. This time course parallels certain immunological properties of C. parvum and suggests a possible mode of action.
微小隐孢子虫的抗肿瘤活性被认为是通过单核细胞/巨噬细胞系统介导的(斯科特,1974年)。这些细胞起源于骨髓中快速分裂的前体细胞,微小隐孢子虫可能正是在此水平发挥其作用。为了验证这一假设,按照布拉德利和梅特卡夫(1966年)的方法培养了骨髓T0瑞士小鼠,该方法可得出处死时增殖巨噬细胞前体细胞数量的指标。在单次腹腔注射700微克微小隐孢子虫抗肿瘤菌株(CN 6134 - 威康研究实验室)后的不同时间进行了实验。对照组注射700微克白喉杆菌CN 2000或微小隐孢子虫CN 5888(一种无抗肿瘤活性的菌株)。在治疗后2小时至3周的各个时间段,接受“活性”微小隐孢子虫的小鼠的巨噬细胞集落计数显著高于对照组。这一时间进程与微小隐孢子虫的某些免疫特性相似,并提示了一种可能的作用方式。